壁内转移是食管鳞状细胞癌复发的危险因素
该回顾性研究分析743例食管鳞状细胞癌(ESCC)根治性食管切除术患者,其中41例(5.5%)检出壁内转移(IM)。IM与更大肿瘤、更晚T/N分期及更高组织学分级相关,多因素分析显示IM是复发的独立危险因素(p=0.002),IM患者5年无复发生存率仅6.1%,显著低于无IM者的43.5%(p<0.001)。
要点
- 743例食管鳞癌切除患者中41例(5.5%)检出壁内转移。
- IM是复发的独立危险因素(p=0.002),5年无复发生存率6.1% vs 43.5%。
核心结论
- 壁内转移(IM)与TNM分期等解剖学决定因素一样,可能是食管鳞状细胞癌(ESCC)患者的重要预后因素。
研究设计与样本
- 回顾性分析743例接受食管切除术的食管鳞状细胞癌(ESCC)患者,其中41例(5.5%)检出壁内转移(IM),探讨IM的临床病理特征及其对术后复发的影响。
- 共纳入710例男性患者和33例女性患者,平均年龄64.4±7.7岁,中位随访98.5个月。
主要发现
- IM与肿瘤较大(p<0.001)、T分期晚(p<0.001)、N分期晚(p<0.001)及组织学分级高(p<0.023)相关。
- 51.2%的患者术前检出IM,转移灶中位大小2.0 cm(范围0.1至6.4 cm),原发肿瘤至转移灶中位距离2.5 cm(范围0.5至21.0 cm),46.3%的患者见多发转移。
- 多因素分析显示T分期晚(p<0.001)、N分期晚(p<0.001)及IM存在(p=0.002)是复发的独立危险因素。
- IM患者5年无复发生存率为6.1%,无IM患者为43.5%(p<0.001)。
临床怎么用
- 作者认为,有效的术前评估和术后监测可能有助于改善ESCC患者的结局,尤其当伴有IM时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to assess the clinicopathologic implications of intramural metastasis (IM) in patients with esophageal squamous cell carcinoma (ESCC). METHODS: We retrospectively analyzed 743 patients who underwent esophagectomy. Among these patients, IM was detected in 41 patients (5.5%). The clinicopathologic features of IM and its influence on postoperative recurrence were investigated. RESULTS: In total, 710 male patients and 33 female patients with a mean age of 64.4 ± 7.7 years were included. The median follow-up period was 98.5 months. IM was associated with large tumor size (p < 0.001), advanced T stage (p < 0.001), advanced N stage (p < 0.001), and advanced histologic grade (p < 0.023). IM was detected preoperatively in 51.2% of patients, and the median size of the metastasis was 2.0 cm (range: 0.1 to 6.4 cm). The median distance from the primary tumor to the metastasis was 2.5 cm (range: 0.5 to 21.0 cm); multiple metastases were observed in 46.3% of patients. Multivariable analyses revealed that advanced T stage (p < 0.001), advanced N stage (p < 0.001), and IM presence (p = 0.002) were independent risk factors for recurrence. The 5-year recurrence-free survival was 6.1% for patients with IM and 43.5% for patients without IM (p < 0.001). CONCLUSIONS: IM could be an important prognostic factor, along with anatomic determinants such as the TNM staging system, in patients with ESCC. Effective preoperative evaluation and postoperative surveillance may help improve the outcome of patients with ESCC, particularly when accompanied by IM.
引用
- Moon DH, Jeon JH, Yang HC, et al. Intramural Metastasis as a Risk Factor for Recurrence in Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 2018. PMID: 29534955. doi:10.1016/j.athoracsur.2018.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。